2l8j
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==GABARAPL-1 NBR1-LIR complex structure== | ==GABARAPL-1 NBR1-LIR complex structure== | ||
- | <StructureSection load='2l8j' size='340' side='right' caption='[[2l8j]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''> | + | <StructureSection load='2l8j' size='340' side='right'caption='[[2l8j]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[2l8j]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[2l8j]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2L8J OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2L8J FirstGlance]. <br> |
- | </td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">GABARAPL1, GEC1 ([ | + | </td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">GABARAPL1, GEC1 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2l8j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2l8j OCA], [https://pdbe.org/2l8j PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2l8j RCSB], [https://www.ebi.ac.uk/pdbsum/2l8j PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2l8j ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
- | [[ | + | [[https://www.uniprot.org/uniprot/GBRL1_HUMAN GBRL1_HUMAN]] Increases cell-surface expression of kappa-type opioid receptor through facilitating anterograde intracellular trafficking of the receptor. Involved in formation of autophagosomal vacuoles.<ref>PMID:16431922</ref> <ref>PMID:20404487</ref> [[https://www.uniprot.org/uniprot/NBR1_HUMAN NBR1_HUMAN]] Acts probably as a receptor for selective autophagosomal degradation of ubiquitinated targets.<ref>PMID:19250911</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 20: | Line 20: | ||
==See Also== | ==See Also== | ||
- | *[[GABA | + | *[[GABA receptor-associated protein 3D structures|GABA receptor-associated protein 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
Line 26: | Line 26: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
+ | [[Category: Large Structures]] | ||
[[Category: Dikic, I]] | [[Category: Dikic, I]] | ||
[[Category: Doetsch, V]] | [[Category: Doetsch, V]] |
Revision as of 07:38, 14 April 2021
GABARAPL-1 NBR1-LIR complex structure
|